Table 2.
A hypothetical data of 10 ulcerative colitis cases and 10 controls with their survival time and survival status
| Patient ID | Survival time (t in weeks) | Event | Group | Age (in years) | ESR (mm/h) | C-Reactive protein (mg/L) |
|---|---|---|---|---|---|---|
| UC-A | 8 | Failed | Treatment | 30 | 44.09 | 11 |
| UC-B | 4 | Censored | Treatment | 26 | 32.04 | 13 |
| UC-C | 8 | Failed | Treatment | 23 | 29.03 | 12 |
| UC-D | 6 | Failed | Treatment | 47 | 23.09 | 8 |
| UC-E | 18 | Censored | Treatment | 56 | 15.09 | 4 |
| UC-F | 5.5 | Censored | Treatment | 36 | 14.80 | 5 |
| UC-G | 10 | Censored | Treatment | 19 | 33.12 | 2 |
| UC-H | 14 | Failed | Treatment | 29 | 10 | 1 |
| UC-I | 10 | Censored | Treatment | 44 | 11.23 | 0.02 |
| UC-J | 4 | Failed | Treatment | 60 | 38.03 | 2.3 |
| CC-A | 2 | Failed | Placebo | 24 | 23.09 | 11 |
| CC-B | 3 | Failed | Placebo | 29 | 21.45 | 14 |
| CC-C | 4 | Failed | Placebo | 34 | 8.08 | 10 |
| CC-D | 4 | Failed | Placebo | 45 | 6.03 | 09 |
| CC-E | 8 | Failed | Placebo | 43 | 32.01 | 4 |
| CC-F | 11 | Failed | Placebo | 21 | 10.09 | 20 |
| CC-G | 12 | Failed | Placebo | 58 | 11.34 | 34 |
| CC-H | 17 | Failed | Placebo | 33 | 18.33 | 1 |
| CC-I | 15 | Failed | Placebo | 27 | 13.7 | 4 |
| CC-J | 8 | Failed | Placebo | 18 | 11 | 5 |
CC control case, CRP C-reactive protein, ESR erythrocyte sedimentation rate, UC ulcerative colitis